Dowpharma has a 30-year record of secure, timely and compliant supply of APIs and intermediates. The differentiated technology and full service offerings enable Dowpharma to support both big pharmaceutical and small and emerging (virtual) companies alike. Virtual pharmaceutical companies can especially benefit from proven capabilities around process scale-up, analytical development, validation and regulatory support. Core technology offerings from Dowpharma support the preparation of chiral intermediates (RSM's) and include biocatalysis, asymmetric hydrogenation (including the DuPhos™ catalysts), asymmetric allylic alkylation (Trost technology), asymmetric hydroformylation, crystallization-based resolution and chiral pool starting materials.
|Postal address:||574 Building|
|Email:||Contact us now|